Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

68.58
Delayed Data
As of Apr 27
 +0.36 / +0.53%
Today’s Change
65.38
Today|||52-Week Range
101.78
-4.23%
Year-to-Date
Gilead, NetApp, First Solar Could Profit Most on Trump's Tax Plan
Apr 27 / TheStreet.com - Paid Partner Content
What to Expect from Prothena (PRTA) This Earnings Season?
Apr 26 / Zacks.com - Paid Partner Content
United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss
Apr 27 / Zacks.com - Paid Partner Content
Surveying the NASH Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
BioMarin (BMRN) Q1 Earnings: Will it Beat Estimates Again?
Apr 27 / Zacks.com - Paid Partner Content
What's in Store for Merck (MRK) this Earnings Season?
Apr 26 / Zacks.com - Paid Partner Content
Benedict Financial Advisors Inc Buys Stanley Black & Decker, TransCanada, Gilead Scie...
Apr 27 / GuruFocus News - Paid Partner Content
Pfizer (PFE) Q1 Earnings: Will it Pull Off a Surprise?
Apr 26 / Zacks.com - Paid Partner Content
Tmd & Associates, Inc Buys WisdomTree MidCap Earnings Fund, WisdomTree SmallCap Earni...
Apr 26 / GuruFocus News - Paid Partner Content
Surveying the NASH Liver-Disease Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close68.22
Today’s open68.17
Day’s range68.05 - 68.76
Volume6,734,653
Average volume (3 months)9,677,187
Market cap$89.2B
Dividend yield3.03%
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-28.82%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-5.37%
P/E ratio6.9
Price/Sales3.21
Price/Book4.73

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-3.41-1.22%
AMGNAmgen-1.89-1.15%
ILMNIllumina Inc-0.84-0.46%
BIVVBioverativ Inc+0.15+0.26%
Data as of 04/27/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$2.27
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts